Sjögren's Syndrome and the Periorbital Area in HOF

Among the many questions of the medical history, "do you have dry eye?" often gets a shrug. In Sjögren's syndrome, that answer is central. The autoimmune disease affects the glands that produce tears and saliva, and dry eye can be intense and persistent. For the HOF professional, this raises a safety question: is the area we are about to work on already sitting on a fragile ocular surface?

This page brings together the review reasoning on Sjögren's syndrome and procedures in the periorbital area, with attention to botulinum toxin and fillers. It is not a protocol. Clinical decisions belong to the qualified professional, according to their professional council's rules (in Brazil), and follow-up of the disease belongs to the responsible physician.

What is Sjögren's syndrome?

Sjögren's syndrome is an autoimmune disease in which the immune system mainly attacks the exocrine glands, including the tear and salivary glands. The result is dry eye and dry mouth, which may come with fatigue, joint pain and other manifestations. It can appear on its own or together with other autoimmune diseases. Diagnosis and follow-up are done by doctors, usually rheumatologists, with support from the ophthalmologist.

For the HOF practice, the manifestations that matter most are:

• Dry eye. A gritty feeling, burning, redness, reflex tearing and fluctuating vision.
• Dry, sensitive skin. Lower tolerance to antiseptics, friction and irritating products.
• Dry mouth. Can affect comfort in perioral procedures and the hygiene routine.
• Underlying autoimmune disease. It goes into screening alongside other conditions; see autoimmune diseases and fillers.

Why does the periorbital area need special attention?

The muscles around the eyes, especially the orbicularis oculi, take part in blinking and eyelid closure. Blinking spreads the tear film over the cornea. When the eye already produces few tears, any change in blink dynamics can have a greater effect than in a healthy eye.

Two situations can be relevant:

• Botulinum toxin that reduces the activity of periorbital muscles can weaken or slow eyelid closure, favoring tear film evaporation. In rare cases, incomplete eyelid closure (lagophthalmos) can occur.
• Drooping of the eyelid or brow (eyelid ptosis) changes how tears are distributed and how comfortable the eye feels.

The mechanisms and complications are described in dry eye and lagophthalmos after toxin and eyelid ptosis vs brow ptosis.

What should you ask and examine in the consultation?

The direct question about dry eye is the starting point, and it is worth going deeper with a few details that show severity. Examining the ocular surface is the ophthalmologist's job, but the HOF professional can observe external signs and decide whether referral is needed.

When the condition is significant or poorly controlled, coordinating with the rheumatologist and the ophthalmologist is the best approach before any procedure near the eyes. Record the conversation and the decision in the patient record.

How should you think about toxin in this patient?

In general review terms, a few points are taken into account.

Periorbital anatomy helps in understanding the relationships between muscle, eyelid and tear film. For general content, see botulinum toxin: fundamentals and botulinum toxin for crow's feet. The conversation with the patient should include the possibility of worsening dry eye, of ptosis and what to do if it happens.

And fillers in the area?

In the tear trough area, the skin is thin, the support is delicate and vascular risk is relevant. A patient with Sjögren's may have even more fragile periorbital skin and a tendency to swelling. The indication is individual, with assessment of the type of tear trough, the volume and the risk; see tear troughs: types and assessment and visual complication after filler.

Points of caution, at review level:

• High vascular risk area: hyaluronidase and the emergency plan must be on hand.
• Swelling can last longer in fragile skin.
• Eye pain, reduced vision or visual changes after the procedure are an ophthalmological emergency.
• The patient should be told the result may be subtle and that alternatives exist.

How do you guide the patient?

A patient with Sjögren's knows their own dry eye well and usually keeps eye drops close by. Use that familiarity: explain that the procedure may change how the eye feels and agree on what to do, such as keeping the usual eye drops, avoiding contact lenses that day, watching for signs and reporting early.

Record the guidance and the informed consent, with a mention of dry eye and the possible consequences.

What about other areas of the face?

Not every procedure affects the eye. The lips, lower third and jawline have only a distant relationship with the tear film. But dry skin and dry mouth still matter: tolerance to antiseptics and the aftercare routine may need adjusting. The planning conversation can be broader, considering the patient's priorities. If the main concern is a tired-looking gaze, it is worth reading tired look: assessment before deciding on the periorbital area.

Where Harmy helps

For a patient who needs more caution, the projection helps decide with fewer procedures. Seeing in the image that a specific area makes a difference avoids injecting where the gain is small.

If you want to understand how these areas are marked in the app, see the guides to marking the tear trough and marking the glabella.

Takeaways

In Sjögren's syndrome, the safety question is about the eye. Ask about dry eye in every medical history, assess severity, be cautious with periorbital toxin, keep the emergency plan for fillers, coordinate with the responsible doctors when the condition is significant and record the guidance and consent.